معالجة فقر الدم

Georgopoulos D, Matamis D, Routsi C, Michalopoulos A, Maggina N, Dimopoulos G, Zakynthinos E, Nakos G, Thomopoulos G, Mandragos K, Maniatis A; Critical Care Clinical Trials Greek Group.

Source‎: Crit Care 2005;9(5):R508-15.

مفهرسة‎: PubMed 16277712

DOI‎: 10.1186/cc3786

https://www.ncbi.nlm.nih.gov/pubmed/16277712 (يفتح نافذة جديدة)

Management of a Jehovah's Witness patient with sepsis and profuse bleeding after emergency coronary artery bypass graft surgery: rethinking the critical threshold of oxygen delivery. (يفتح نافذة جديدة)

Hong T, Shander A, Agarwal S, Castresana M.

Source‎: A A Case Rep 2015;4(10):127-31.

مفهرسة‎: PubMed 25974416

DOI‎: 10.1213/XAA.0000000000000144

https://www.ncbi.nlm.nih.gov/pubmed/25974416 (يفتح نافذة جديدة)

Management strategies for perioperative anaemia in the severely burn-injured Jehovah's Witness patients who decline a blood transfusion: a systematic review with illustrative case reports. (يفتح نافذة جديدة)

Jung M, Harish V, Wijewardena A, Kerridge I, Gillies R

Source‎: Burns. 2023 49(3):716-29. Epub 2022 Jul 18.

مفهرسة‎: PubMed 35941026

DOI‎: 10.1016/j.burns.2022.07.002

https://pubmed.ncbi.nlm.nih.gov/35941026/ (يفتح نافذة جديدة)

Long-term ECMO treatment in Jehovah's Witness patient without transfusions. (يفتح نافذة جديدة)

Lindholm J, Palmér K, Frenckner B.

Source‎: Perfusion 2012;27(4):332-4.

مفهرسة‎: PubMed 22496111

DOI‎: 10.1177/0267659112444328

https://www.ncbi.nlm.nih.gov/pubmed/22496111 (يفتح نافذة جديدة)

Outcomes with the use of recombinant human erythropoietin in critically ill burn patients. (يفتح نافذة جديدة)

Lundy JB, Hetz K, Chung KK, Renz EM, White CE, King BT, Huzar T, Wolf SE, Blackbourne LH

Source‎: Am Surg 2010;76(9):951-6.

مفهرسة‎: PubMed 20836341

https://www.ncbi.nlm.nih.gov/pubmed/20836341 (يفتح نافذة جديدة)

Safety of off-label erythropoiesis stimulating agents in critically ill patients: a meta-analysis. (يفتح نافذة جديدة)

Mesgarpour B, Heidinger BH, Schwameis M, Kienbacher C, Walsh C, Schmitz S, Herkner H.

Source‎: Intensive Care Med 2013;39(11):1896-908.

مفهرسة‎: PubMed 23928897

DOI‎: 10.1007/s00134-013-3030-9

https://www.ncbi.nlm.nih.gov/pubmed/23928897 (يفتح نافذة جديدة)

Transfusion-free treatment strategies for acute anemia in critical care. (يفتح نافذة جديدة)

Morgan CA, Byul Sarah S, Forest CP.

Source‎: JAAPA 2016;29(8):38-44.

مفهرسة‎: PubMed 27467297

DOI‎: 10.1097/01.JAA.0000488695.96294.33

https://www.ncbi.nlm.nih.gov/pubmed/27467297 (يفتح نافذة جديدة)

Improved survival of critically ill trauma patients treated with recombinant human erythropoietin. (يفتح نافذة جديدة)

Napolitano LM, Fabian TC, Kelly KM, Bailey JA, Block EF, Langholff W, Enny C, Corwin HL.

Source‎: J Trauma 2008;65(2):285-97.

مفهرسة‎: PubMed 18695463

DOI‎: 10.1097/TA.0b013e31817f2c6e

https://www.ncbi.nlm.nih.gov/pubmed/18695463 (يفتح نافذة جديدة)

Reticulocyte counts and their relation to hemoglobin levels in trauma patients. (يفتح نافذة جديدة)

Otterman ML, Nijboer JM, van der Horst IC, van Meurs M, ten Duis HJ, Nijsten MW

Source‎: J Trauma 2009;67(1):121-4.

مفهرسة‎: PubMed 19590320

DOI‎: 10.1097/TA.0b013e318187a848

https://www.ncbi.nlm.nih.gov/pubmed/19590320 (يفتح نافذة جديدة)

Randomized, double-blind, placebo-controlled trial of effects of enteral iron supplementation on anemia and risk of infection during surgical critical illness. (يفتح نافذة جديدة)

Pieracci FM, Henderson P, Rodney JR, Holena DN, Genisca A, Ip I, Benkert S, Hydo LJ, Eachempati SR, Shou J, Barie PS.

Source‎: Surg Infect (Larchmt) 2009;10(1):9-19.

مفهرسة‎: PubMed 19245362

DOI‎: 10.1089/sur.2008.043

https://www.ncbi.nlm.nih.gov/pubmed/19245362 (يفتح نافذة جديدة)

How do we treat life-threatening anemia in a Jehovah's Witness patient? (يفتح نافذة جديدة)

Posluszny JA Jr, Napolitano LM.

Source‎: Transfusion 2014;54(12):3026-34.

مفهرسة‎: PubMed 25330835

DOI‎: 10.1111/trf.12888

https://www.ncbi.nlm.nih.gov/pubmed/25330835 (يفتح نافذة جديدة)

Recombinant human erythropoietin use in a critically ill Jehovah's Witness after cardiac surgery. (يفتح نافذة جديدة)

Price S, Pepper JR, Jaggar SI.

Source‎: Anesth Analg 2005;101(2):325-7.

مفهرسة‎: PubMed 16037136

DOI‎: 10.1213/01.ANE.0000159158.70532.D0

https://www.ncbi.nlm.nih.gov/pubmed/16037136 (يفتح نافذة جديدة)

Successful rescue therapy for severe acute anemia: managing the critically ill Jehovah's Witness. (يفتح نافذة جديدة)

Rebel A, Beck A, Efron P, Bavry AA, Ang D.

Source‎: Am Surg 2015;81(6):e263-5.

مفهرسة‎: PubMed 26031262

https://www.ncbi.nlm.nih.gov/pubmed/26031262 (يفتح نافذة جديدة)

Erythropoietin response is blunted in critically ill patients. (يفتح نافذة جديدة)

Rogiers P, Zhang H, Leeman M, Nagler J, Neels H, Mélot C, Vincent JL

Source‎: Intensive Care Med 1997;23(2):159-62.

مفهرسة‎: PubMed 9069000

DOI‎: 10.1007/s001340050310

https://www.ncbi.nlm.nih.gov/pubmed/9069000 (يفتح نافذة جديدة)

Life-threatening postoperative blood loss in a Jehovah's Witness, treated with high-dose erythropoietin. (يفتح نافذة جديدة)

Schälte G, Janz H, Busse J, Jovanovic V, Rossaint R, Kuhlen R.

Source‎: Br J Anaesth 2005;94(4):442-4.

مفهرسة‎: PubMed 15653706

DOI‎: 10.1093/bja/aei068

https://www.ncbi.nlm.nih.gov/pubmed/15653706 (يفتح نافذة جديدة)

Management of anemia in patients who decline blood transfusion. (يفتح نافذة جديدة)

Shander A, Goodnough LT

Source‎: Am J Hematol 2018;93(9):1183-91.

مفهرسة‎: PubMed 30033541

DOI‎: 10.1002/ajh.25167

https://pubmed.ncbi.nlm.nih.gov/30033541/ (يفتح نافذة جديدة)

Erythropoiesis-stimulating agent administration and survival after severe traumatic brain injury: a prospective study. (يفتح نافذة جديدة)

Talving P, Lustenberger T, Inaba K, Lam L, Mohseni S, Chan L, Demetriades D.

Source‎: Arch Surg 2012;147(3):251-5.

مفهرسة‎: PubMed 22430906

DOI‎: 10.1001/archsurg.2011.1838

https://www.ncbi.nlm.nih.gov/pubmed/22430906 (يفتح نافذة جديدة)

Intravenous iron following cardiac surgery does not increase the infection rate. (يفتح نافذة جديدة)

Torres S, Kuo YH, Morris K, Neibart R, Holtz JB, Davis JM.

Source‎: Surg Infect (Larchmt) 2006;7(4):361-6.

مفهرسة‎: PubMed 16978079

DOI‎: 10.1089/sur.2006.7.361

https://www.ncbi.nlm.nih.gov/pubmed/16978079 (يفتح نافذة جديدة)

Erythropoietin improves long-term neurological outcome in acute ischemic stroke patients: a randomized, prospective, placebo-controlled clinical trial. (يفتح نافذة جديدة)

Tsai TH, Lu CH, Wallace CG, Chang WN, Chen SF, Huang CR, Tsai NW, Lan MY, Sung PH, Liu CF, Yip HK

Source‎: Crit Care 2015;19:49.

مفهرسة‎: PubMed 25888250

DOI‎: 10.1186/s13054-015-0761-8

https://www.ncbi.nlm.nih.gov/pubmed/25888250 (يفتح نافذة جديدة)

Pharmacotherapy for reducing RBC transfusion for patients in the ICU: a systematic review and network meta-analysis. (يفتح نافذة جديدة)

Yoshihiro S, Hongo T, Yamamoto M, Taito S, Kataoka Y

Source‎: Crit Care Med 2024;52(4):618-25.

مفهرسة‎: PubMed 37962159

DOI‎: 10.1097/CCM.0000000000006114

https://pubmed.ncbi.nlm.nih.gov/37962159/ (يفتح نافذة جديدة)

العناية الفائقة والحالات الحرجة

معالجة فقر الدم

العربية

معالجة فقر الدم

https://assetsnffrgf-a.akamaihd.net/assets/ct/d8f8c0370e/images/syn_placeholder_sqr.png

Pharmacokinetics and pharmacodynamics of six epoetin alfa dosing regimens in anemic critically ill patients without acute blood loss. (يفتح نافذة جديدة)

Recombinant human erythropoietin therapy in critically ill Jehovah's Witnesses. (يفتح نافذة جديدة)

Reducing postburn injury anemia in a Jehovah's Witness patient. (يفتح نافذة جديدة)

A US multicenter, retrospective, observational study of erythropoiesis-stimulating agent utilization in anemic, critically ill patients admitted to the intensive care unit. (يفتح نافذة جديدة)

Severe acute anemia after liver transplantation in an elderly Jehovah's Witness treated with high-dose erythropoietin and ferric carboxymaltose: a case report. (يفتح نافذة جديدة)

Recombinant human erythropoietin in severe anaemia: issues of dosing and duration. (يفتح نافذة جديدة)

Efficacy of recombinant human erythropoietin in the critically ill patient: a randomized, double-blind, placebo-controlled trial. (يفتح نافذة جديدة)

Erythropoietin for critically ill trauma patients: a missed opportunity? (يفتح نافذة جديدة)

Postoperative management of severe acute anemia in a Jehovah's Witness. (يفتح نافذة جديدة)

Restrictive transfusion in geriatric trauma patients. (يفتح نافذة جديدة)

High-dose recombinant human erythropoietin stimulates reticulocyte production in patients with multiple organ dysfunction syndrome. (يفتح نافذة جديدة)

Recombinant human erythropoietin therapy in critically ill patients: a dose-response study [ISRCTN48523317]. (يفتح نافذة جديدة)

Management of a Jehovah's Witness patient with sepsis and profuse bleeding after emergency coronary artery bypass graft surgery: rethinking the critical threshold of oxygen delivery. (يفتح نافذة جديدة)

Management strategies for perioperative anaemia in the severely burn-injured Jehovah's Witness patients who decline a blood transfusion: a systematic review with illustrative case reports. (يفتح نافذة جديدة)

Long-term ECMO treatment in Jehovah's Witness patient without transfusions. (يفتح نافذة جديدة)

Outcomes with the use of recombinant human erythropoietin in critically ill burn patients. (يفتح نافذة جديدة)

Safety of off-label erythropoiesis stimulating agents in critically ill patients: a meta-analysis. (يفتح نافذة جديدة)

Transfusion-free treatment strategies for acute anemia in critical care. (يفتح نافذة جديدة)

Improved survival of critically ill trauma patients treated with recombinant human erythropoietin. (يفتح نافذة جديدة)

Reticulocyte counts and their relation to hemoglobin levels in trauma patients. (يفتح نافذة جديدة)

Randomized, double-blind, placebo-controlled trial of effects of enteral iron supplementation on anemia and risk of infection during surgical critical illness. (يفتح نافذة جديدة)

How do we treat life-threatening anemia in a Jehovah's Witness patient? (يفتح نافذة جديدة)

Recombinant human erythropoietin use in a critically ill Jehovah's Witness after cardiac surgery. (يفتح نافذة جديدة)

Successful rescue therapy for severe acute anemia: managing the critically ill Jehovah's Witness. (يفتح نافذة جديدة)

Erythropoietin response is blunted in critically ill patients. (يفتح نافذة جديدة)

Life-threatening postoperative blood loss in a Jehovah's Witness, treated with high-dose erythropoietin. (يفتح نافذة جديدة)

Management of anemia in patients who decline blood transfusion. (يفتح نافذة جديدة)

Erythropoiesis-stimulating agent administration and survival after severe traumatic brain injury: a prospective study. (يفتح نافذة جديدة)

Intravenous iron following cardiac surgery does not increase the infection rate. (يفتح نافذة جديدة)

Erythropoietin improves long-term neurological outcome in acute ischemic stroke patients: a randomized, prospective, placebo-controlled clinical trial. (يفتح نافذة جديدة)

Pharmacotherapy for reducing RBC transfusion for patients in the ICU: a systematic review and network meta-analysis. (يفتح نافذة جديدة)

لجنة الاتصال بالمستشفيات (‏ل‌ام)‏

رُزَم معلومات للأطباء

الفيديوات

معالجة فقر الدم

اختر لغتك

مشاركة